dc.contributor.author | Karakulak, Ç | |
dc.contributor.author | Uskur, TB | |
dc.contributor.author | Güzel, E | |
dc.contributor.author | Karataş, OF | |
dc.contributor.author | Shahzadi, ANDLEEB | |
dc.contributor.author | YAZICI, Zeliha | |
dc.contributor.author | Özen, M | |
dc.date.accessioned | 2021-03-04T10:03:29Z | |
dc.date.available | 2021-03-04T10:03:29Z | |
dc.identifier.citation | Shahzadi A., Karakulak Ç., Karataş O., Güzel E., Uskur T., Özen M., YAZICI Z., "Interaction between doxorubicin and ciprofloxacin: CYP1A1, CYP1A2, CYP2J3 and CYP3A1 mRNA expression in Sprague Dawley rats.", International Symposium on Advances in Predictive & Personalized Medicine, İstanbul, Türkiye, 2 - 03 Nisan 2015, ss.101 | |
dc.identifier.other | av_6b524840-736c-49ed-80dd-79254f55d076 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/74211 | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Meslek Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.title | Interaction between doxorubicin and ciprofloxacin: CYP1A1, CYP1A2, CYP2J3 and CYP3A1 mRNA expression in Sprague Dawley rats. | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.contributor.firstauthorID | 283079 | |